Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Paediatric research

Erythropoietin provides neuroprotection to preterm infants

Premature baby in an incubator

Source: Fanfo / Shutterstock.com

Neuroprotection for premature babies may lie in giving them erythropoietin

Preterm infants are at risk of developing encephalopathy of prematurity, which is characterised by structural changes in the brain and long-term neurodevelopmental delay. Treatment options are limited, but new data reported in JAMA (online, 27 August 2014)[1] suggest that erythropoietin could provide neuroprotection to preterm infants.

Preliminary findings from the Swiss EPO Neuroprotection Trial found that preterm infants given three doses of recombinant human erythropoietin just before and just after birth were significantly less likely to have brain abnormalities on magnetic resonance imaging than infants given placebo.

“These findings require assessment in a randomised trial designed primarily to assess this outcome, as well as investigation of the association with neurodevelopmental outcomes,” conclude Petra Susan Hüppi, from University Hospital of Geneva, Switzerland, and her co-authors.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066304

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.